Table 1.
Relationship Between miR-15b Expression Level in Glioma Specimens and Gender, Age, Tumor Location, KPS Score and WHO Grade
| miR-15b expression | ||||
|---|---|---|---|---|
| Clinical features | No. of case | High (n, %) | Low (n, %) | p-Value |
| Gender | 0.821 | |||
| Male | 58 | 27 | 31 | |
| Female | 34 | 15 | 19 | |
| Age | 0.763 | |||
| <55 | 41 | 18 | 23 | |
| ≥55 | 51 | 24 | 27 | |
| Tumor location | 0.641 | |||
| Frontal | 35 | 16 | 19 | |
| Temporal | 29 | 15 | 14 | |
| Other | 28 | 11 | 17 | |
| KPS | 0.001 | |||
| <80 | 52 | 16 | 36 | |
| ≥80 | 40 | 26 | 14 | |
| WHO grade | <0.001 | |||
| WHO I–II | 29 | 25 | 4 | |
| WHO III | 39 | 17 | 22 | |
| WHO IV | 24 | 0 | 24 | |
KPS, Karnofsky performance scale; miR-15b, microRNA-15b; WHO, World Health Organization.